Growth Hormone Treatment Not Yet Recruiting Phase 0 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)Not Yet Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05660356
Growth Hormone Deficiency in Mild Traumatic Brain InjuryTreatment